AlphaCentric Advisors’s MorphoSys AG American Depositary Shares MOR Stock Holding History

AlphaCentric Advisors’s Portfolio MOR Stock Details MOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-185,000	Closed	-$1.24M	–	291
2023 Q3	$1.24M	Hold	185,000	–	–	0.71%	46
2023 Q2	$1.38M	Hold	185,000	–	–	0.77%	49
2023 Q1	$731K	Hold	185,000	–	–	0.5%	69
2022 Q4	$662K	Hold	185,000	–	–	0.65%	57
2022 Q3	$931K	Buy	+185,000	New	+$956K	0.96%	28
2021 Q4	$1.37M	Buy	145,500 +44,500	+44%	+$472K	0.4%	14
2021 Q3	$1.19M	Buy	101,000 +55,500	+122%	+$804K	0.3%	17
2021 Q2	$876K	Buy	45,500 +26,500	+139%	+$567K	0.24%	30
2021 Q1	$414K	Buy	19,000 +13,800	+265%	+$369K	0.14%	54
2020 Q4	$147K	Buy	+5,200	New	+$142K	0.06%	87

Other funds holding MOR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AlphaCentric Advisors's MOR Position: Q4 2023 in Review

AlphaCentric Advisors sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2023, closing a stake of 185,000 shares — an estimated $1.24M sold.

AlphaCentric Advisors first reported a position in MOR in Q4 2020 and held it in 10 quarters. The position peaked at $1.38M in Q2 2023. 54 funds tracked by Wall St. Rank hold MOR as of Q4 2023.

AlphaCentric Advisors reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2023 after selling out during the quarter.
AlphaCentric Advisors sold 185,000 MorphoSys AG American Depositary Shares shares in Q4 2023, an estimated $1.24M.
AlphaCentric Advisors first reported a position in MorphoSys AG American Depositary Shares in Q4 2020 and held it in 10 quarters.
AlphaCentric Advisors's MorphoSys AG American Depositary Shares position peaked at $1.38M in Q2 2023.
54 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2023.

Based on AlphaCentric Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.